Axonal Growth and Fasciculation of Spinal Neurons Promoted by Aldynoglia in Alkaline Fibrin Hydrogel: Influence of Tol-51 Sulfoglycolipid
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25179173 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Vinnitsa Buzoianu-Anguiano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla La Mancha, 45071 Toledo, Spain. Hauptthemen laut MEDLINE: Ganglia, Spinal, Axons, Fibrin. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospital Nacional de Parapléjicos de Toledo, Servicio de Salud de Castilla La Mancha.
Abstract (Originalsprache)
Traumatic spinal cord injury (tSCI) has complex pathophysiological events that begin after the initial trauma. One such event is fibroglial scar formation by fibroblasts and reactive astrocytes. A strong inhibition of axonal growth is caused by the activated astroglial cells as a component of fibroglial scarring through the production of inhibitory molecules, such as chondroitin sulfate proteoglycans or myelin-associated proteins. Here, we used neural precursor cells (aldynoglia) as promoters of axonal growth and a fibrin hydrogel gelled under alkaline conditions to support and guide neuronal cell growth, respectively. We added Tol-51 sulfoglycolipid as a synthetic inhibitor of astrocyte and microglia in order to test its effect on the axonal growth-promoting function of aldynoglia precursor cells. We obtained an increase in GFAP expression corresponding to the expected glial phenotype for aldynoglia cells cultured in alkaline fibrin. In co-cultures of dorsal root ganglia (DRG) and aldynoglia, the axonal growth promotion of DRG neurons by aldynoglia was not affected. We observed that the neural precursor cells first clustered together and then formed niches from which aldynoglia cells grew and connected to groups of adjacent cells. We conclude that the combination of alkaline fibrin with synthetic sulfoglycolipid Tol-51 increased cell adhesion, cell migration, fasciculation, and axonal growth capacity, promoted by aldynoglia cells. There was no negative effect on the behavior of aldynoglia cells after the addition of sulfoglycolipid Tol-51, suggesting that a combination of aldynoglia plus alkaline fibrin and Tol-51 compound could be useful as a therapeutic strategy for tSCI repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla La Mancha, 45071 Toledo, Spain.
- Departamento de Química Bio-Orgánica, Instituto de Química Orgánica General (IQOG-CSIC), CSIC, 28006 Madrid, Spain.
ORCID-Profile: Vinnitsa Buzoianu-Anguiano, Alejandro Arriero-Cabañero, Alfonso Fernández-Mayoralas, Ernesto Doncel-Pérez
Förderung
- Hospital Nacional de Parapléjicos de Toledo, Servicio de Salud de Castilla La Mancha
Zitieren
APA
Buzoianu-Anguiano, V., Arriero-Cabañero, A., Fernández-Mayoralas, A., Torres-Llacsa, M., & Doncel-Pérez, E. (2024). Axonal Growth and Fasciculation of Spinal Neurons Promoted by Aldynoglia in Alkaline Fibrin Hydrogel: Influence of Tol-51 Sulfoglycolipid. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179173
Vancouver
Buzoianu-Anguiano V, Arriero-Cabañero A, Fernández-Mayoralas A, Torres-Llacsa M, Doncel-Pérez E. Axonal Growth and Fasciculation of Spinal Neurons Promoted by Aldynoglia in Alkaline Fibrin Hydrogel: Influence of Tol-51 Sulfoglycolipid. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179173
BibTeX
@article{BuzoianuAnguiano2024,
author = {Buzoianu-Anguiano, Vinnitsa and Arriero-Cabañero, Alejandro and Fernández-Mayoralas, Alfonso and Torres-Llacsa, Mabel and Doncel-Pérez, Ernesto},
title = {Axonal Growth and Fasciculation of Spinal Neurons Promoted by Aldynoglia in Alkaline Fibrin Hydrogel: Influence of Tol-51 Sulfoglycolipid},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25179173}
}
EUVIMED